✦ LIBER ✦

Hypomanic symptoms assessed by the HCL-32 in patients with major depressive disorder: A multicenter trial across China

✍ Scribed by Yang, Hai-Chen; Xiang, Yu-Tao; Liu, Tie-Bang; Han, Rong; Wang, Gang; Hu, Chen; Li, Ling-Jiang; Wang, Xiao-Ping; Peng, Hong-Jun; Si, Tian-Mei; Fang, Yi-Ru; Yuan, Cheng-Mei; Lu, Zheng; Hu, Jian; Chen, Zhi-Yu; Huang, Yi; Sun, Jing; Li, Hui-Chun; Zhang, Jin-Bei; Angst, Jules

Book ID: 118016301
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 243 KB
Volume: 143
Category: Article
ISSN: 0165-0327
DOI: 10.1016/j.jad.2012.06.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PW01-39 - Characteristics of patients wi

PW01-39 - Characteristics of patients with hypomanic symptoms presenting a current major depressive episode identified with the HCL-32 patient questionnaire

✍ Vieta, E.; Angst, J.; Azorin, J.-M.; Bowden, C.L.; Perugi, G.; Young, A.H. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 French ⚖ 35 KB

A double-blind, multicenter trial compar

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder

✍ Lesley M. Arnold; Yili Lu; Leslie J. Crofford; Madelaine Wohlreich; Michael J. D 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## Objective To assess the efficacy and safety of duloxetine, a serotonin and norepinephrine reuptake inhibitor, in subjects with primary fibromyalgia, with or without current major depressive disorder. ## Methods This study was a randomized, double‐blind, placebo‐controlled trial co

Assessment of depressive symptoms and fu

Assessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocol

✍ Tina Marie Myers Oakes; Adam L. Myers; Lauren B. Marangell; Jonna Ahl; Apurva Pr 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 3 views

Objective Return of functional ability is a central goal in the treatment of major depressive disorder. We conducted two trials with the same protocol that was designed to assess functioning after 8 Weeks of treatment with duloxetine. Methods The a priori primary outcome was improvement in the Hamil

A double-blind, placebo-controlled treat

A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: The relevance of the placebo effect and psychological symptoms

✍ Renerio Fraguas; Renata Martinho da Silva Telles; Tânia Correa Toledo Ferraz Alv 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 226 KB

The third Symptom Management Research Tr

The third Symptom Management Research Trial in Oncology (SMaRT Oncology-3): a randomised trial to determine the efficacy of adding a complex intervention for major depressive disorder (Depression Care for People with Lung Cancer) to usual care, compared to usual care alone in patients with lung cancer

✍ Jane Walker; Jim Cassidy; Michael Sharpe; SMaRT Oncology-3 Trialists 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 174 KB